MOH
Molina Healthcare, Inc.NYSEHealthcare$139.38+2.62%ClosedMarket Cap: $7.18B
As of 2026-04-06
Valuation
P/E (TTM)
15.21
PEG
—
P/B
1.74
P/S
0.16
EV/EBITDA
7.05
DCF Value
$1,144.20
FCF Yield
-8.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
9.0%
Operating Margin
1.7%
Net Margin
1.0%
ROE
11.0%
ROA
3.5%
ROIC
7.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $11.38B | 6.2% | $-162.0M | $-160.0M | $-3.15 | — |
| FY 2025 | $45.43B | 9.0% | $781.0M | $472.0M | $8.92 | — |
| Q3 2025 | $11.48B | 8.1% | $137.0M | $79.0M | $1.50 | — |
| Q2 2025 | $11.43B | 10.2% | $373.0M | $255.0M | $4.74 | — |
| Q1 2025 | $11.15B | 11.5% | $433.0M | $298.0M | $5.45 | — |
| Q4 2024 | $10.50B | 10.6% | $380.0M | $251.0M | $4.35 | — |
| FY 2024 | $40.65B | 11.7% | $1.71B | $1.18B | $20.42 | — |
| Q3 2024 | $10.34B | 11.5% | $467.0M | $326.0M | $5.65 | — |
| Q2 2024 | $9.88B | 12.3% | $434.0M | $301.0M | $5.17 | — |
| Q1 2024 | $9.93B | 12.3% | $426.0M | $301.0M | $5.16 | — |
| Q4 2023 | $9.05B | 11.5% | $316.0M | $216.0M | $3.71 | — |
| FY 2023 | $34.07B | 12.7% | $1.57B | $1.09B | $18.78 | — |